Clinical Trials Logo
  1. Home
  2. Refractory Angina Pectoris
  3. NCT02499250

Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients — D-RIC-RAP  

Refractory Angina Pectoris Clinical Trial

Official title:
Effect of Daily Remote Ischemic Conditioning on the Life Quality of Refractory Angina Pectoris Patients and the Mechanism

Clinical Trial Summary

The purpose is to test whether daily ischemic conditioning of the arms over 30 days could reduce the frequency and severity of angina pectoris and improve the life quality of refractory angina pectoris patients.

Clinical Trial Description

Refractory angina pectoris denotes "chronic stable angina that persists despite optimal medication and when revascularisation is unfeasible or where the risks are unjustified". These patients could potentially be relieved by non-conventional treatments like remote ischemic conditioning, and actually this effect has been observed in several cases in the center of the sponsor. This study is a pilot study to measure the efficacy and safety of this method in this group of patients. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02499250
Study type Interventional
Source Navy General Hospital, Beijing
Contact Li Zhao, MD,PhD
Phone 86-10-66951416
Email zhaoli463700@foxmail.com
Status Recruiting
Phase N/A
Start date January 2015
Completion date January 2017
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05711849 - Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina Phase 2
Withdrawn NCT03438500 - Cardiac Shock Wave Treatment in Patients With Reduced Coronary Flow Reserve N/A
Recruiting NCT01711099 - Efficacy of Extracorporeal Shockwave Myocardial Revascularization N/A
Active, not recruiting NCT03039751 - Adenovirus Vascular Endothelial Growth Factor D (AdvVEGF-D) Therapy for Treatment of Refractory Angina Pectoris Phase 2
Suspended NCT01567592 - Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris Phase 1
Active, not recruiting NCT01241968 - Extracorporeal Shock Wave Therapy for the Treatment of Ischemic Heart Disease Phase 2
Completed NCT01219218 - Extracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris Phase 1
Active, not recruiting NCT01567644 - Extracorporeal Shockwave Therapy for the Treatment of Refractory Chronic Angina Pectoris Phase 1
Completed NCT00662727 - Extracorporeal Shockwave Therapy for the Treatment of Refractory Angina Pectoris Phase 2
Completed NCT04121845 - CoROnary SinuS Reducer implantatiOn for ischemiA reDuction N/A
Active, not recruiting NCT05174572 - IMR Evaluation in Patients With Coronary Sinus Reducer Implantation (INROAD Study) N/A
Recruiting NCT04915157 - Efficacy of Spinal Cord Stimulation in Patients With Refractory Angina Pectoris N/A
Completed NCT01508910 - Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina Phase 3